Press "Enter" to skip to content

New patent expiration for Alnylam Pharms drug ONPATTRO

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for Alnylam Pharms drug ONPATTRO

Annual Drug Patent Expirations for ONPATTRO
Annual Drug Patent Expirations for ONPATTRO

Onpattro is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twenty-one patents protecting this drug.

Drug patent litigation for ONPATTRO.

This drug has four hundred patent family members in thirty-four countries.

The generic ingredient in ONPATTRO is patisiran sodium. Additional details are available on the patisiran sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Alnylam Pharms drug ONPATTRO
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions